HARVEST is here! Learn all about our new agri-tech accelerator supporting Canadian companies strengthening the agriculture and food economy.
Biotechnology is a critical driver of better health and a stronger bio-based economy in Ontario. This Strategic Vision sets Ontario Genomics’ direction for the next five years: to turn our scientific and commercial strengths into much-needed solutions that reach patients, customers, and markets faster.
With two missions supporting one vision, we can build a competitive, resilient bio-based economy, supported by the distinct pathways necessary to achieve it. Precision health requires clinical evidence, trusted data, and adoption within a patient-centred health system. Food and industrial biotechnology need strong unit economics, greater sustainability, integration of value chains, and access to scale-up pathways.
We will focus our ambitions on accelerating commercialization that delivers real uptake, strengthening the platforms that enable responsible collaboration within each mission.
In precision health, we will drive $500M in new investment into the Canadian health ecosystem, sequencing the genomes of 100,000 people in Canada via a shared platform governed by responsible data use practices.
In food and industrial biotechnology, we will see $100M in direct industry funding for research and development, accessible scale-up capacity up to 10,000L, with made-in-Ontario upcycled bio-based products on the market.
This plan is designed for execution, with clear ambitions and outcomes across both missions. Working with partners across Ontario and beyond, we will turn game-changing progress in biotechnology into tangible benefits for individuals, communities and our economy.
